| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| REGAL PARTNERS HOLDINGS PTY LTD | 9% | +25% | $1,362,952,390 | +$629,253,691 | 320,694,680 | +86% | Regal Partners Holdings Pty Limited | 31 Dec 2025 |
As of 31 Dec 2025, 8 institutional investors reported holding 347,943 shares of Radiopharm Theranostics Ltd - Ordinary Shares, no par value and American Depositary Shares, each representing three hundred Ordinary Shares, no par value (RADX). This represents 0.01% of the company’s total 3,543,587,624 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 347,943 | $1,816,097 | +$184,816 | $5.22 | 8 |
| 2025 Q3 | 312,506 | $1,725,033 | -$119,409 | $5.52 | 4 |
| 2025 Q2 | 339,690 | $1,576,875 | -$15,543 | $4.64 | 5 |
| 2025 Q1 | 342,915 | $1,649,421 | -$446,370 | $4.81 | 3 |
| 2024 Q4 | 435,803 | $1,939,576 | +$1,939,576 | $4.49 | 4 |